Home › High Blood Pressure › NCT04832009
Reversing Glucose and Lipid-mediated Vascular Dysfunction
RecruitingEarly phase 1Healthy volunteers welcome
Reversing Glucose and Lipid-mediated Vascular Dysfunction (REGAL)
Who can join
Ages 18 to 79 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Lean: BMI \< 25 kg/m * Normal insulin sensitivity: (calculation based on fasting glucose and insulin concentrations in blood) * Middle-aged: 18-79 years * Blood pressure: \< 140 (systolic) and \< 90 mmHg (diastolic * Weight stable (+/- 5 lbs) for the previous 3 months * Participants must be willing and able to discontinue taking any vitamin C or E supplements or omega-3 fatty acids beginning 2 weeks prior. * Able and willing to provide written informed consent Exclusion Criteria: * Diabetes mellitus Type I or Type II: fasting glucose \< 126 mg/dL and/or HbA1c \< 6.5% * Current smoker or History of smoking in the past 3 months. * Hyperlipidemia: Fasting triglycerides \< 250 mg/dL * Hypertension: \>130/80 mmHg * History of heart disease (e.g., myocardial infarction, stent, heart attack, stroke, heart failure, valvular heart disease, cardiomyopathy) * History of vascular disease (e.g., bypass, stroke)
About the study
The purpose of our study is to understand the extent to which the blood vessels are affected by glucose and fat (lipids) in lean healthy adults and if these changes in the blood vessels contribute to the development of high blood pressure.
What is being tested
- Dextrose 20 % in 500 ML Injection (drug)
- Intralipid (drug)
- Saline (drug)
- Ascorbic acid (drug)
Sponsor: University of Kansas Medical Center · Participants: 46 · Started: May 9, 2022
Contact the study team
- Seth W Holwerda, PhD · Phone: 9729223230
- Davina A Clonch · Phone: 9132266009
Official record on ClinicalTrials.gov — NCT04832009
Locations in the U.S.
| Kansas | University of Kansas Medical Center, Kansas City |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.